News and insights
Welcome to Bellberry’s blog. Here we publish commentary, updates, feature posts and thought leadership on research ethics, regulation, participant experience and system change. Discover what’s happening across the research and ethics landscape in Australia and beyond.
From Lab To Life Podcast: Episode 1
Listen to our brand new podcast series, ‘From Lab To Life’, where we go behind the scenes to understand more about the clinical trial and medical research sector. You’ll hear from experts in the sector, including researchers, clinical trial participants and members of Human Research Ethics Committees, exploring challenges and opportunities facing the health and medical […]
Read More
International Symposium Statement Released
In June 2023 Bellberry were delighted to host the “Towards a Coordinated Approach for Managing Accelerated Patient Access to Potentially Beneficial Medicines: Balancing Patient, Regulator, Health Technology Assessment (HTA), Payer, and Other Stakeholder Needs” international workshop in Adelaide. This event brought together over a global delegation from over 20 nations including the US, UK, Europe, Canada, Singapore, […]
Read More
Bellberry Not-For-Profit Business of the Year Award Winners!
Bellberry were thrilled to win the 2023 Not-For-Profit Business of the Year Award at Friday’s South Australian Premier’s Business and Export Awards! What a great way to kick off our 20th year celebrations – thanks to our amazing Bellberry community.
Read More
Bellberry Clinical Trial Activity Report for 2022
On International Clinical Trials Day, we’re proud to publish the Bellberry Clinical Trial Activity Report for 2022. This annual publication represents over one third of the Australia wide CTN trial activity across the development lifecycle. This report demonstrates capability and capacity in a broad range of research areas. It also captures the originating funding location […]
Read More
Quality update: progress and final reporting refresher
Progress reporting realignment initiative During 2021 Bellberry implemented a new approach to annual reporting, making use of technology solutions to improve performance. The primary objectives of the project were to: Support researchers maintain compliance with the terms and conditions of ethical approval and obligations under the National Statement on Ethical Conduct in Human Research. Move […]
Read More
Bellberry Clinical Trial Activity Report 2021
On International Clinical Trials Day, we’re proud to publish the Bellberry Clinical Trial Activity Report 2021. This second annual publication represents a significant proportion of the Australia wide CTN trial activity across the development lifecycle. It demonstrates capability and capacity in a broad range of research areas. The report also captures the originating funding location […]
Read More
Bellberry Quality Update: HREC membership lists
As per the National Statement on Ethical Conduct in Human Research (2007) Updated 2018, at the end of each HREC meeting, Bellberry Administration creates a ‘Member List’ as per the example below: The member composition at the meeting may change from protocol to protocol, in consideration of the expertise required and conflicts of interest. The […]
Read More
Safety reporting requirements update
As most of our users have now formalised local governance processes for internal safety reporting, we have updated MAR G2 Safety reporting, to no longer require the submission of SUSARs for individual events at Bellberry sites. To assist sites in understanding the updated requirements, if Bellberry’s administrative team receives documentation not outlined in MAR […]
Read More
Progress and Final Reporting Refresher
Progress reporting realignment initiative We have seen significant improvement with compliance since Bellberry began a significant progress reporting realignment initiative. The primary objectives of the project were to: Progress and final reporting: guidance materials Bellberry provides the following documents relating to progress and final reporting: MAR G4 Progress and final reports This guidance outlines researcher […]
Read More
Radiation Refresher
Bellberry provides the following documents relating to applications that involve radiation: BA G13 Ionising RadiationThis guidance outlines the requirements where research applications involve the use of ionising radiation. BA F13.1.1 Standard clauses – ionising radiationThis form provides sites with example clauses for inclusion in the PICF.If the medical imaging used is the same as standard […]
Read More
Bellberry Clinical Trial Activity Report 2020
Bellberry is the largest independent reviewer of CTN trials in Australia. This year on Clinical Trials Day, we’re pleased to share a summary report which describes research activity overseen by Bellberry HRECs through 2020. This activity report represents a significant proportion of the Australia wide CTN trial activity across the development lifecycle. It demonstrates […]
Read More
Site-specific clauses document update
Bellberry has updated the site-specific clauses document (BA F1.1.12) to include examples and a pre-submission checklist. Please note the following: Please see the updated form here.
Read More
Process changes at Bellberry
It is now several months since Bellberry updated its procedures and we are pleased to report that there has been a significant drop in start-up times for additional sites. The table beneath is a comparator of Jan/Mar 2020 to 2021. These months have been chosen as Jan/Mar may pre-date any COVID related issues sites may […]
Read More
Study Submission Changes
Bellberry’s mission is to protect the welfare of research participants and to improve the quality, efficiency and effectiveness of research. Whenever possible, we are always striving to make improvements to streamline the HREC process. In November 2020, several important changes to the Bellberry submission process came into effect. The transition period for these changes has […]
Read More
Study Submission Changes
Bellberry’s mission is to protect the welfare of research participants and to improve the quality, efficiency and effectiveness of research. Whenever possible, we are always striving to make improvements to streamline the HREC process. As of 2 November 2020, several important changes to the Bellberry submission process will come into effect. Bellberry will assist sites […]
Read More
Human Research Ethics Committees
Discover how Bellberry's committees operate and maintain the highest ethical standards in research.
Learn More
Monitoring & Quality
Learn about Bellberry's continuous improvement and oversight processes that ensure accountability.
Learn More
Grant Activities
See how Bellberry reinvests in research education and participant-focused initiatives.
Learn More